What Do Women in the U.S. Know about Human Papillomavirus and Cervical Cancer?

Tiro, Jasmin A.; Meissner, Helen I.; Kobrin, Sarah C.; Chollette, Veronica

doi:10.1158/1055-9965.epi-06-0756

Cited by 199 publications

(185 citation statements)

References 41 publications

(62 reference statements)

Supporting

Mentioning

143

Contrasting

Unclassified

Order By: Relevance

“…White caregivers and those with some college education had higher HPV knowledge. Our findings are consistent with studies that identified racial differences in awareness and knowledge of HPV, the HPV vaccine, and cervical cancer (13,14,24). Studies have also found awareness of HPV to be lower among the less educated and higher among non-Hispanic Whites (13,14).…”

Section: Discussionsupporting

confidence: 92%

“…Despite the proven efficacy of HPV vaccines and a surge in media coverage of cancer-related topics in recent years, past research suggests that this new prevention strategy is little understood by the public (12)(13)(14)(15). A review of seven studies found that 58% of respondents had never heard of HPV (12).…”

Section: Introductionmentioning

confidence: 99%

“…Awareness was especially low among certain groups, including adolescents, lowerincome individuals, and minorities (16). Moreover, HPV awareness did not ensure accurate knowledge (14), and many did not know that HPV can cause cervical cancer (12,14,17). However, all of these studies occurred before the HPV vaccine became available.…”

Section: Introductionmentioning

confidence: 99%

“…Thus, harnessing the power of media is one way to educate the public on this important and timely issue. Experts have called for more health communication efforts around HPV, the HPV vaccine, and cervical cancer (14,24,34), and persistent disparities in cervical cancer call for interventions that target high-risk groups.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Disparities in How Parents Are Learning about the Human Papillomavirus Vaccine

Hughes¹,

Cates

Liddon

et al. 2009

Cancer Epidemiology, Biomarkers &Amp; Prevention

164

131

View full text Add to dashboard Cite

Background: Differential access to basic health information may contribute to persistent cervical cancer disparities. We examined whether human papillomavirus (HPV) vaccine awareness, HPV knowledge, and use of information sources about the vaccine differ by sociodemographic characteristics associated with cervical cancer. Methods: Study participants (n = 889) were caregivers of adolescent girls ages 10 to 18 years living in southeastern North Carolina. Analyses simultaneously controlled for caregivers' gender, race, age, education, income, and rural residence. Results: Although most caregivers were aware of HPV (83%) and the HPV vaccine (82%), awareness differed by gender, race, education, and income. The largest differences were for race, with 87% of Whites versus 68% of African Americans having heard of the vaccine (P < 0.001). Caregivers correctly answered an average of 69% of questions on HPV, with differences by race

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Disparities in How Parents Are Learning about the Human Papillomavirus Vaccine

Hughes¹,

Cates

Liddon

et al. 2009

Cancer Epidemiology, Biomarkers &Amp; Prevention

164

131

View full text Add to dashboard Cite

show abstract

“…Strategies to enforce the knowledge of HPV transmission, prevention, detection as well as risk and management of cervical neoplasia are necessary for all societies. 31 Our cross-sectional results showed that the improvement of sensitivity with additional HPV testing was only 15.3%. The whole project is still ongoing to evaluate safety and cost-effectiveness of screening with Pap plus HPV testing at longer intervals, which can be answered after longterm follow-up.…”

Section: Discussionmentioning

confidence: 65%

Cervical cancer screening program integrating Pap smear and HPV DNA testing: A population‐based study

Chao

Hsu

Lai

et al. 2008

Intl Journal of Cancer

View full text Add to dashboard Cite

We conducted a population-based cohort study to evaluate the complementary value of HPV testing to Papanicolaou (Pap) smear and the prevalence and genotype distribution of HPV in Taiwan. In this report, we described the design of the whole study and analyzed the cross-sectional results. Female residents (age 30 years) of Taoyuan, Taiwan were invited. After signing informed consent, every participant had a Pap smear and a HPV testing. Patients with Pap atypical squamous cell of undetermined significance (Group I) or those with HPV-positive but normal cytology (Group II) were referred for a colposcopic examination. A total of 10,014 women were eligible. The overall HPV prevalence was 10.8% (95% confidence interval 10.5%-11.4%) in the study population. A total of 37 types of HPV were identified and the leading three were HPV-52, -18 and -58. There was a significant positive correlation of HPV prevalence with older age, postmenopausal status, current-user of oral contraceptives and never-user of hormone replacement therapy. Past users of oral contraceptives and never users of Pap were associated with higher risk of abnormal Pap, while age 40-49 strata had lower risk. Fifty-nine cases of cervical intraepithelial neoplasia (CIN) 2 from Group I and additional 11 from Group II were identified. The improvement of sensitivity with additional HPV testing was 15.3%. Besides, no specific subgroup was found to most benefit from the combined strategy. The value of adding HPV test to conventional Pap smear has to be evaluated after longer-term follow-up of this population-based cohort. ' 2008 Wiley-Liss, Inc.Key words: cervical cancer screening; Pap smear; human papillomavirus; polymerase chain reaction (PCR); prevalence Cervical cancer continues to be one of the leading female genital cancers worldwide. 1 The cervical cancer burden in Taiwan is still heavy with the incidence of invasive cancer being 24.5/ 100,000, which ranked the fifth place of cancer death in women. 2 Traditionally, primary screening of cancer precursors remains based on cytological classification of cervical smears. Conventional Papanicolaou (Pap) test or monolayer cytology provided sensitivity rates ranged from 30% to 87% and specificity rates from 86% to 100%. 3 Since human papillomavirus (HPV) has been established as a well-recognized etiologic agent of cervical neoplasia, HPV DNA testing is a promising alternative or complementary test to improve the efficacy of cervical screening and probably cost-effective, depending on screening interval. 4,5 Cervical cancer screening programs integrating HPV testing have been advocated in United Kingdom, United States, South Africa, Thailand and Germany. [6][7][8][9][10] Hybrid Capture assay (HCII) (Digene Corporation, Gaithersburg, MD) is the most widely used method of HPV DNA testing. HCII utilizes liquid hybridization of RNA probes against HPV DNA followed by signal amplification, has been validated for its reproducibility. 11 Methods using PCR is more sensitive and quality assays were generally consistent for...

show abstract